DUPILUMAB

dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes

DUPILUMAB (12302L)

dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes
12302L
Body System:
Manner of administration:Injection
Public
S100 HSD Public
Authority Required

Restriction

Indication: Uncontrolled severe asthma
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 2 # of repeats: 5 DPMQ: $1,609.86 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Dupixent